🎬 India key for Netflix's global growth, says Ted Sarandos

Ted Sarandos stated that India is central to Netflix's next growth phase due to its huge appetite for entertainment. The co-CEO noted that India has 20-25 million paid users out of a 325 million global base. Netflix learned that audiences are value-conscious and require consistent, varied content across all genres. While they won't bid for full IPL rights, they focus on unique, eventisable live sports moments. Ultimately, success in India means balancing revenue with significant cultural impact. 🤩

🚀 Can Sunny Deol match Ranveer Singh's profit streak?

Ranveer Singh currently holds the record as the only actor with two films netting over 300 crore in profit. Sunny Deol is eyeing this spot with his upcoming movie, Batwara 1947. His previous hit, Gadar 2 in 2023, secured him one entry into this club with a 450.50 crore net profit. Now, the performance of Batwara 1947, directed by Rajkumar Santoshi and produced by Aamir Khan, is crucial. If it hits 300 crore profit, Deol will become the second actor to achieve this milestone. 💰

🔬 New genetics point to fibromyalgia as brain disorder

New research in Nature Medicine suggests fibromyalgia is fundamentally a central nervous system disorder. The study was a meta-analysis across 2,563,755 individuals, identifying 26 risk loci linked to brain and neural genes. This provides strong evidence supporting a neural disease model over an autoimmune one. Genetic overlap was found with conditions like PTSD and IBS, suggesting shared pathways. Future treatments might utilize targeted brain stimulation based on these gene findings. 🧠

🎬 Ajay Devgn aims for historic 300 crore with Drishyam 3

Ajay Devgn is aiming to script history with the upcoming film Drishyam 3. The movie is expected to be a major hit for him in the Indian box office. Drishyam 2 grossed a solid 241 crore net, leading to a minimum target of 300 crore net for the threequel. This film could become the first Indian threequel to hit the 300-crore net mark in India. Drishyam 3 is scheduled for release on Gandhi Jayanti, October 2, 2026. 🎬

🌬️ Benralizumab cuts mucus in severe asthma patients

Treatment with benralizumab significantly lowered the overall mucus burden in patients suffering from severe eosinophilic asthma. The multicenter phase 4 study took place between October 2022 and July 2024 involving 39 patients across various sites. Mucus volume dropped by 61% from a mean of 0.21 mL to 0.08 mL at week 13. This reduction correlated with better breathing function, while safety remained favorable with no reported deaths. These results support previous findings on improving asthma control in poorly managed eosinophilic asthma. 🌬️

🛡️ Taiwan starts war games drills

Taiwan has initiated a series of war games to enhance its national defense capabilities. These exercises are being conducted across various military bases within Taiwan. The drills commenced on a specified date, with participation from multiple armed forces units. The purpose of these exercises is to prepare for potential regional conflicts and bolster readiness. Further details regarding the scale and outcomes of these games are expected in the coming weeks. 🛡️

👃 Sinus surgery helps life quality for polyp patients

Both full and limited Functional Endoscopic Sinus Surgery (FESS) significantly boosted quality of life for patients with chronic rhinosinusitis and nasal polyps. The study, conducted at two Finnish university hospitals, included 97 patients aged around 47 years. Results showed significant reductions in HRQOL scores at 12 and 24 months post-surgery for both groups. While full FESS showed better short-term results for anosmia and polyp scores, both approaches reduced oral corticosteroid use. Doctors suggest limited FESS is useful for cases where general anesthesia is risky.

🔬 New EAU guidelines revamp how UTIs are managed

The European Association of Urology released its 2026 guidelines, introducing major updates for managing urinary tract infections. These guidelines, relevant for clinicians across Europe, replace the old 'complicated' vs 'uncomplicated' UTI classification. Infections are now sorted into localized or systemic types based on clinical presentation, like fever or dysuria. The updates strongly stress antibiotic stewardship, advising against treating asymptomatic bacteriuria in most cases. Clinicians must now assess individual patient risk factors for successful treatment outcomes.

🎬 Dhamaal 4's Box Office Run Slows Down

Dhamaal 4, starring Ajay Devgn, is wrapping up its run below Raid 2 despite being the top film in the franchise. On Tuesday, day 26, it earned 1.11 crore worldwide, with 1.06 crore from India. In total, its 26-day worldwide gross stands at 229.48 crore. This performance means it will remain Ajay Devgn’s 6th highest-grossing film globally. The film is now 13.09 crore away from surpassing Raid 2. 📉

📉 Raghav Juyal's new film struggling at box office

Raghav Juyal's debut solo lead film, Bhai Tera Star Hai, is facing a tough start at the domestic box office. It was released on July 31, clashing with Spider-Man: Brand New Day, leading to a low screen count. Over six days, the film earned a net total of 1.02 crore, which is disappointing for a comedy. Collections dropped sharply after the initial opening, showing little growth over the weekend. The film is now expected to end its extended opening week under 1.5 crore, facing a big loss. 📉

🎬 Odyssey hits 150 Cr mark in India 🍿

The Odyssey has achieved a major milestone, grossing 150.26 crore net at the Indian box office. This success is attributed to the film's performance across 19 days, starring Christopher Nolan in India. On day 19, the movie earned an estimated 2.15 crore, which is a 7.5% jump from the previous day. This achievement makes it Nolan's first 150 crore net grosser and the 8th highest-grossing Hollywood film in the country. The film is now aiming for a lifetime collection between 170-175 crore net.